Global Myasthenia Gravis Market Witnessed to Gain Momentum Due to Constant Development of Novel Therapeutics


Albany, NY — 12/29/2017 — According to a study, autoimmune diseases come in many different forms, affecting millions of people. Myasthenia Gravis is such an autoimmune disease resulting from some abnormality which leads to an incorrect flow of chemicals in the nervous system. In the present time, the global myasthenia gravis market is treading a growth path owing to the need to prevent worsening of quality of life due to myasthenia gravis. There are various research being done by pharmaceutical companies to provide better treatment for the patients fighting the disease. To elaborate further, Market Research Hub (MRH) has broadcasted a new study titled “Myasthenia Gravis Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025″ to its wide repository, which offers in-depth analysis value of the myasthenia gravis market. Geographically, the report also consists of overall myasthenia gravis market analysis for the regions, including Asia Pacific, Latin America, North America, Europe, and Middle East & Africa.

Request For Sample Report:

Report Overview

In this 161-page study, a detailed overview of market dynamics, including the drivers, restraints, and opportunities of the myasthenia gravis market, along with porter's analysis, regulatory scenario for myasthenia gravis treatment, pipeline assessment for upcoming treatment options for myasthenia gravis, and market strategies adopted by top players of the global myasthenia gravis market, has been provided. Apart from that, market revenue analysis for all the major segments has been provided for the forecast period of 2017-2025, considering 2016 as the base year, along with compound annual growth rate (CAGR %) for the given forecast.

Key findings

Myasthenia gravis is an autoimmune disorder and neuromuscular disorder that causes muscle weakness. The condition is characterized by fatigue and weakness of skeletal muscles. Muscles that monitor swallowing and breathing, eye movement, eyelids, and shoulder and facial muscles are the ones that are usually impacted in myasthenia gravis. Research and development for therapeutics for myasthenia gravis are stoking growth of myasthenia gravis market. As per the evaluations, global myasthenia gravis market is anticipated to be worth US$2,313.1 mn by the end of 2025 from its valuation of US$975.1 mn in 2016. During the forecast period of 2017 and 2025, the global myasthenia gravis market is projected to clock a tremendous CAGR of 10.1%.

Prime focus on research and development for novel therapeutics for myasthenia gravis is one of the key strategic moves adopted by companies operating in the myasthenia gravis market. Key market players profiled in this report include F. Hoffmann-La Roche AG, Baxter International, Inc., Takeda Pharmaceutical Company Limited, Alexion Pharmaceutical Inc., Avadel Pharmaceuticals, PLC. (Flamel Technologies), CSL Behring, Grifols, S.A., Shire plc, Novartis AG, and Valeant Pharmaceuticals International, Inc.

Browse Full Report with TOC-

On the basis of the treatment type global myasthenia gravis market is segmented into drug treatment, rapid immunotherapies, and Thymectomy. It has been analyzed that, as there is lack of targeted therapy in myasthenia gravis management, use of monoclonal antibodies in treating myasthenia gravis is likely to give paradigm shift in myasthenia gravis market. Rituximab is additional monoclonal antibody therapeutic agent which is under clinical trials for myasthenia gravis management.

Among the key regional segments, North America has emerged as a key market for myasthenia gravis on account of a considerable prevalence of myasthenia gravis in the U.S.

Enquire about this Report-

About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH's expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Us
90 State Street,
Albany, NY 12207,
United States
Toll Free : 800-998-4852 (US-Canada)
Email : [email protected]
Website :
Read Industry News at –

Powered by WPeMatico